CNMD CONMED Corporation
USHealthcareAs of 2026-07-10 16:00
Why CNMD matters now
CONMED Corporation (CNMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $38.48 with +4.88% on the session and $1.16B in market capitalization; recent performance reads 1-month -9.95% and YTD -19.75%.
The latest financial table shown here is Q1 2026, with revenue of $317.0M, net income of $13.8M, and EPS of $0.45. Investors can compare that operating picture with valuation signals such as P/E 24.07 and FCF yield 12.6%.
The latest indexable market news headline is "CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026" from Business Wire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $78.00; recent insider activity includes Lockwood Kimberly filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
24.07
PEG
—
P/B
0.98
P/S
0.71
EV/EBITDA
10.65
DCF Value
$131.79
FCF Yield
12.6%
Div Yield
1.2%
Margins & Returns
Gross Margin
53.6%
Operating Margin
11.2%
Net Margin
4.0%
ROE
5.4%
ROA
2.4%
ROIC
5.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $317.0M | $13.8M | $0.45 |
| Q4 2025 | $373.5M | $16.7M | $0.54 |
| FY 2025 | $1.37B | $47.1M | $1.51 |
| Q3 2025 | $338.6M | $2.9M | $0.09 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$78.00
Target (Median)
$78.00
Target Range
$61.00 - $95.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.92
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.